ShareValue scores for 600594.SHG: Valuation 64, Quality 32, Growth 34, Health 39.

600594.SHG
SSE

Guizhou Yibai Pharmaceutical Co Ltd

CN¥3.75(+6.23%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

2% to 17%
Valuation
64
Fair Value
Price vs Value
Quality
32
Weak
Business Strength
Growth
34
Weak
Revenue & Earnings
Health
39
Stressed
Financial Stability
Momentum
23
Bearish
Price Trend

Company Details

About

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology. The company also engages in investment in the cultivation and breeding projects of medicinal materials; and agricultural products sale, as well as provides market information consulting services for medicinal materials. In addition, it is involved in the research and development, and information consulting services for health food. The company was founded in 1995 and is based in Guiyang, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026